A Harvard University-affiliated teaching hospital is seeking to retract or correct dozens of papers authored by four of its top researchers — including the hospital’s CEO — following a probe into allegations of data falsification. The Dana-Farber Cancer Institute in Boston has already initiated six retractions to papers and 31 others are in the process of being corrected, the hospital’s research integrity officer, Dr. Barrett Rollins, confirmed to the Harvard Crimson. The corrections follow claims of data falsification leveled against the cancer institute’s CEO, Dr. Laurie Glimcher, chief operating officer Dr. William Hahn, director of the Clinical Investigator Research Program...